Share on StockTwits

POZEN (NASDAQ:POZN) CEO John R. Plachetka sold 50,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $7.78, for a total transaction of $389,000.00. Following the completion of the sale, the chief executive officer now directly owns 693,126 shares in the company, valued at approximately $5,392,520. The sale was disclosed in a legal filing with the SEC, which is available at this link.

POZEN (NASDAQ:POZN) traded up 0.92% during mid-day trading on Thursday, hitting $7.72. The stock had a trading volume of 221,420 shares. POZEN has a 52 week low of $5.01 and a 52 week high of $9.90. The stock’s 50-day moving average is $7.99 and its 200-day moving average is $8.31. The company’s market cap is $243.4 million.

POZEN (NASDAQ:POZN) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.09 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.07 by $0.02. The company had revenue of $7.40 million for the quarter, compared to the consensus estimate of $7.10 million. During the same quarter last year, the company posted ($0.13) earnings per share. POZEN’s revenue was up 335.3% compared to the same quarter last year. On average, analysts predict that POZEN will post $0.68 earnings per share for the current fiscal year.

Separately, analysts at Ascendiant Capital Markets upgraded shares of POZEN from a “hold” rating to a “buy” rating in a research note on Friday, August 8th. They now have a $10.00 price target on the stock.

POZEN Inc (NASDAQ:POZN), is a pharmaceutical company focused on transforming medicine.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.